nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimecrolimus—CYP3A4—Esomeprazole—Barrett's esophagus	0.341	0.629	CbGbCtD
Pimecrolimus—CYP3A4—Omeprazole—Barrett's esophagus	0.201	0.371	CbGbCtD
Pimecrolimus—Asthma aggravated—Esomeprazole—Barrett's esophagus	0.0493	0.126	CcSEcCtD
Pimecrolimus—Asthma aggravated—Omeprazole—Barrett's esophagus	0.0493	0.126	CcSEcCtD
Pimecrolimus—MTOR—epithelium—Barrett's esophagus	0.00947	0.185	CbGeAlD
Pimecrolimus—MTOR—smooth muscle tissue—Barrett's esophagus	0.00913	0.178	CbGeAlD
Pimecrolimus—FKBP1A—epithelium—Barrett's esophagus	0.00852	0.167	CbGeAlD
Pimecrolimus—FKBP1A—smooth muscle tissue—Barrett's esophagus	0.00821	0.161	CbGeAlD
Pimecrolimus—Otitis media—Omeprazole—Barrett's esophagus	0.0073	0.0186	CcSEcCtD
Pimecrolimus—Otitis media—Esomeprazole—Barrett's esophagus	0.0073	0.0186	CcSEcCtD
Pimecrolimus—MTOR—digestive system—Barrett's esophagus	0.00721	0.141	CbGeAlD
Pimecrolimus—Eye irritation—Omeprazole—Barrett's esophagus	0.00666	0.017	CcSEcCtD
Pimecrolimus—Eye irritation—Esomeprazole—Barrett's esophagus	0.00666	0.017	CcSEcCtD
Pimecrolimus—FKBP1A—digestive system—Barrett's esophagus	0.00648	0.127	CbGeAlD
Pimecrolimus—Bone disorder—Esomeprazole—Barrett's esophagus	0.00629	0.016	CcSEcCtD
Pimecrolimus—Bone disorder—Omeprazole—Barrett's esophagus	0.00629	0.016	CcSEcCtD
Pimecrolimus—Dysmenorrhoea—Omeprazole—Barrett's esophagus	0.00625	0.0159	CcSEcCtD
Pimecrolimus—Dysmenorrhoea—Esomeprazole—Barrett's esophagus	0.00625	0.0159	CcSEcCtD
Pimecrolimus—Ear pain—Omeprazole—Barrett's esophagus	0.00484	0.0123	CcSEcCtD
Pimecrolimus—Ear pain—Esomeprazole—Barrett's esophagus	0.00484	0.0123	CcSEcCtD
Pimecrolimus—Swelling—Omeprazole—Barrett's esophagus	0.00468	0.0119	CcSEcCtD
Pimecrolimus—Swelling—Esomeprazole—Barrett's esophagus	0.00468	0.0119	CcSEcCtD
Pimecrolimus—Gastroenteritis—Omeprazole—Barrett's esophagus	0.00466	0.0119	CcSEcCtD
Pimecrolimus—Gastroenteritis—Esomeprazole—Barrett's esophagus	0.00466	0.0119	CcSEcCtD
Pimecrolimus—Face oedema—Esomeprazole—Barrett's esophagus	0.00398	0.0102	CcSEcCtD
Pimecrolimus—Face oedema—Omeprazole—Barrett's esophagus	0.00398	0.0102	CcSEcCtD
Pimecrolimus—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.00377	0.00961	CcSEcCtD
Pimecrolimus—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.00377	0.00961	CcSEcCtD
Pimecrolimus—Breast disorder—Esomeprazole—Barrett's esophagus	0.00373	0.0095	CcSEcCtD
Pimecrolimus—Breast disorder—Omeprazole—Barrett's esophagus	0.00373	0.0095	CcSEcCtD
Pimecrolimus—Influenza—Omeprazole—Barrett's esophagus	0.00357	0.00909	CcSEcCtD
Pimecrolimus—Asthma—Omeprazole—Barrett's esophagus	0.00357	0.00909	CcSEcCtD
Pimecrolimus—Asthma—Esomeprazole—Barrett's esophagus	0.00357	0.00909	CcSEcCtD
Pimecrolimus—Influenza—Esomeprazole—Barrett's esophagus	0.00357	0.00909	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.00331	0.00845	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.00331	0.00845	CcSEcCtD
Pimecrolimus—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.00326	0.0083	CcSEcCtD
Pimecrolimus—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.00326	0.0083	CcSEcCtD
Pimecrolimus—Infestation NOS—Omeprazole—Barrett's esophagus	0.00318	0.0081	CcSEcCtD
Pimecrolimus—Infestation—Omeprazole—Barrett's esophagus	0.00318	0.0081	CcSEcCtD
Pimecrolimus—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00318	0.0081	CcSEcCtD
Pimecrolimus—Infestation—Esomeprazole—Barrett's esophagus	0.00318	0.0081	CcSEcCtD
Pimecrolimus—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.00309	0.00788	CcSEcCtD
Pimecrolimus—Conjunctivitis—Omeprazole—Barrett's esophagus	0.00309	0.00788	CcSEcCtD
Pimecrolimus—Epistaxis—Esomeprazole—Barrett's esophagus	0.003	0.00764	CcSEcCtD
Pimecrolimus—Epistaxis—Omeprazole—Barrett's esophagus	0.003	0.00764	CcSEcCtD
Pimecrolimus—Sinusitis—Omeprazole—Barrett's esophagus	0.00298	0.0076	CcSEcCtD
Pimecrolimus—Sinusitis—Esomeprazole—Barrett's esophagus	0.00298	0.0076	CcSEcCtD
Pimecrolimus—Rhinitis—Esomeprazole—Barrett's esophagus	0.00286	0.00729	CcSEcCtD
Pimecrolimus—Rhinitis—Omeprazole—Barrett's esophagus	0.00286	0.00729	CcSEcCtD
Pimecrolimus—Pharyngitis—Omeprazole—Barrett's esophagus	0.00283	0.00722	CcSEcCtD
Pimecrolimus—Pharyngitis—Esomeprazole—Barrett's esophagus	0.00283	0.00722	CcSEcCtD
Pimecrolimus—Eye disorder—Omeprazole—Barrett's esophagus	0.00267	0.0068	CcSEcCtD
Pimecrolimus—Eye disorder—Esomeprazole—Barrett's esophagus	0.00267	0.0068	CcSEcCtD
Pimecrolimus—Flushing—Omeprazole—Barrett's esophagus	0.00265	0.00675	CcSEcCtD
Pimecrolimus—Flushing—Esomeprazole—Barrett's esophagus	0.00265	0.00675	CcSEcCtD
Pimecrolimus—Immune system disorder—Esomeprazole—Barrett's esophagus	0.00258	0.00657	CcSEcCtD
Pimecrolimus—Immune system disorder—Omeprazole—Barrett's esophagus	0.00258	0.00657	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00257	0.00656	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00257	0.00656	CcSEcCtD
Pimecrolimus—Malnutrition—Omeprazole—Barrett's esophagus	0.00248	0.00633	CcSEcCtD
Pimecrolimus—Malnutrition—Esomeprazole—Barrett's esophagus	0.00248	0.00633	CcSEcCtD
Pimecrolimus—Back pain—Omeprazole—Barrett's esophagus	0.0024	0.00613	CcSEcCtD
Pimecrolimus—Back pain—Esomeprazole—Barrett's esophagus	0.0024	0.00613	CcSEcCtD
Pimecrolimus—Angioedema—Omeprazole—Barrett's esophagus	0.00227	0.00579	CcSEcCtD
Pimecrolimus—Angioedema—Esomeprazole—Barrett's esophagus	0.00227	0.00579	CcSEcCtD
Pimecrolimus—Cough—Esomeprazole—Barrett's esophagus	0.00217	0.00553	CcSEcCtD
Pimecrolimus—Cough—Omeprazole—Barrett's esophagus	0.00217	0.00553	CcSEcCtD
Pimecrolimus—CYP3A4—digestive system—Barrett's esophagus	0.00212	0.0414	CbGeAlD
Pimecrolimus—Arthralgia—Esomeprazole—Barrett's esophagus	0.00212	0.00539	CcSEcCtD
Pimecrolimus—Arthralgia—Omeprazole—Barrett's esophagus	0.00212	0.00539	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.0021	0.00535	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.0021	0.00535	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.00203	0.00517	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.00203	0.00517	CcSEcCtD
Pimecrolimus—Infection—Esomeprazole—Barrett's esophagus	0.00201	0.00513	CcSEcCtD
Pimecrolimus—Infection—Omeprazole—Barrett's esophagus	0.00201	0.00513	CcSEcCtD
Pimecrolimus—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00199	0.00507	CcSEcCtD
Pimecrolimus—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00199	0.00507	CcSEcCtD
Pimecrolimus—Skin disorder—Omeprazole—Barrett's esophagus	0.00197	0.00502	CcSEcCtD
Pimecrolimus—Skin disorder—Esomeprazole—Barrett's esophagus	0.00197	0.00502	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.00185	0.00471	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.00185	0.00471	CcSEcCtD
Pimecrolimus—Paraesthesia—Omeprazole—Barrett's esophagus	0.00182	0.00464	CcSEcCtD
Pimecrolimus—Paraesthesia—Esomeprazole—Barrett's esophagus	0.00182	0.00464	CcSEcCtD
Pimecrolimus—Dyspnoea—Omeprazole—Barrett's esophagus	0.00181	0.00461	CcSEcCtD
Pimecrolimus—Dyspnoea—Esomeprazole—Barrett's esophagus	0.00181	0.00461	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00175	0.00446	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00175	0.00446	CcSEcCtD
Pimecrolimus—Pain—Omeprazole—Barrett's esophagus	0.00173	0.00442	CcSEcCtD
Pimecrolimus—Constipation—Omeprazole—Barrett's esophagus	0.00173	0.00442	CcSEcCtD
Pimecrolimus—Pain—Esomeprazole—Barrett's esophagus	0.00173	0.00442	CcSEcCtD
Pimecrolimus—Constipation—Esomeprazole—Barrett's esophagus	0.00173	0.00442	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.00166	0.00423	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.00166	0.00423	CcSEcCtD
Pimecrolimus—Urticaria—Esomeprazole—Barrett's esophagus	0.00161	0.00411	CcSEcCtD
Pimecrolimus—Urticaria—Omeprazole—Barrett's esophagus	0.00161	0.00411	CcSEcCtD
Pimecrolimus—Body temperature increased—Omeprazole—Barrett's esophagus	0.0016	0.00409	CcSEcCtD
Pimecrolimus—Body temperature increased—Esomeprazole—Barrett's esophagus	0.0016	0.00409	CcSEcCtD
Pimecrolimus—Abdominal pain—Esomeprazole—Barrett's esophagus	0.0016	0.00409	CcSEcCtD
Pimecrolimus—Abdominal pain—Omeprazole—Barrett's esophagus	0.0016	0.00409	CcSEcCtD
Pimecrolimus—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.00149	0.00381	CcSEcCtD
Pimecrolimus—Hypersensitivity—Omeprazole—Barrett's esophagus	0.00149	0.00381	CcSEcCtD
Pimecrolimus—Pruritus—Esomeprazole—Barrett's esophagus	0.00143	0.00366	CcSEcCtD
Pimecrolimus—Pruritus—Omeprazole—Barrett's esophagus	0.00143	0.00366	CcSEcCtD
Pimecrolimus—Diarrhoea—Omeprazole—Barrett's esophagus	0.00139	0.00354	CcSEcCtD
Pimecrolimus—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00139	0.00354	CcSEcCtD
Pimecrolimus—Vomiting—Esomeprazole—Barrett's esophagus	0.00129	0.00329	CcSEcCtD
Pimecrolimus—Vomiting—Omeprazole—Barrett's esophagus	0.00129	0.00329	CcSEcCtD
Pimecrolimus—Rash—Omeprazole—Barrett's esophagus	0.00128	0.00326	CcSEcCtD
Pimecrolimus—Rash—Esomeprazole—Barrett's esophagus	0.00128	0.00326	CcSEcCtD
Pimecrolimus—Dermatitis—Omeprazole—Barrett's esophagus	0.00128	0.00326	CcSEcCtD
Pimecrolimus—Dermatitis—Esomeprazole—Barrett's esophagus	0.00128	0.00326	CcSEcCtD
Pimecrolimus—Headache—Omeprazole—Barrett's esophagus	0.00127	0.00324	CcSEcCtD
Pimecrolimus—Headache—Esomeprazole—Barrett's esophagus	0.00127	0.00324	CcSEcCtD
Pimecrolimus—FKBP1A—TGF-beta Receptor Signaling—BMP4—Barrett's esophagus	0.00127	0.0904	CbGpPWpGaD
Pimecrolimus—Nausea—Omeprazole—Barrett's esophagus	0.0012	0.00307	CcSEcCtD
Pimecrolimus—Nausea—Esomeprazole—Barrett's esophagus	0.0012	0.00307	CcSEcCtD
Pimecrolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—PTGS2—Barrett's esophagus	0.000711	0.0508	CbGpPWpGaD
Pimecrolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—HGF—Barrett's esophagus	0.00069	0.0493	CbGpPWpGaD
Pimecrolimus—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000628	0.0448	CbGpPWpGaD
Pimecrolimus—MTOR—BDNF signaling pathway—CRTC1—Barrett's esophagus	0.000618	0.0442	CbGpPWpGaD
Pimecrolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—APC—Barrett's esophagus	0.000512	0.0366	CbGpPWpGaD
Pimecrolimus—MTOR—ErbB1 downstream signaling—SLC9A1—Barrett's esophagus	0.000398	0.0284	CbGpPWpGaD
Pimecrolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000361	0.0258	CbGpPWpGaD
Pimecrolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000361	0.0258	CbGpPWpGaD
Pimecrolimus—MTOR—IL2 signaling events mediated by PI3K—RELA—Barrett's esophagus	0.000338	0.0242	CbGpPWpGaD
Pimecrolimus—MTOR—Wnt Signaling Pathway Netpath—APC—Barrett's esophagus	0.00033	0.0236	CbGpPWpGaD
Pimecrolimus—MTOR—Wnt Signaling Pathway Netpath—PPARG—Barrett's esophagus	0.000318	0.0227	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HGF—Barrett's esophagus	0.000315	0.0225	CbGpPWpGaD
Pimecrolimus—MTOR—TSLP Signaling Pathway—RELA—Barrett's esophagus	0.00028	0.02	CbGpPWpGaD
Pimecrolimus—MTOR—TSLP Signaling Pathway—CXCL8—Barrett's esophagus	0.000263	0.0188	CbGpPWpGaD
Pimecrolimus—MTOR—CDC42 signaling events—APC—Barrett's esophagus	0.00026	0.0186	CbGpPWpGaD
Pimecrolimus—MTOR—SREBP signalling—PPARG—Barrett's esophagus	0.000254	0.0181	CbGpPWpGaD
Pimecrolimus—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.00025	0.0179	CbGpPWpGaD
Pimecrolimus—MTOR—RANKL/RANK Signaling Pathway—RELA—Barrett's esophagus	0.000246	0.0176	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—APC—Barrett's esophagus	0.000234	0.0167	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—PTGS2—Barrett's esophagus	0.000231	0.0165	CbGpPWpGaD
Pimecrolimus—MTOR—IL12-mediated signaling events—RELA—Barrett's esophagus	0.00023	0.0164	CbGpPWpGaD
Pimecrolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000229	0.0164	CbGpPWpGaD
Pimecrolimus—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000226	0.0161	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—CXCL8—Barrett's esophagus	0.000224	0.016	CbGpPWpGaD
Pimecrolimus—MTOR—Oncostatin M Signaling Pathway—RELA—Barrett's esophagus	0.000216	0.0154	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000207	0.0148	CbGpPWpGaD
Pimecrolimus—MTOR—Leptin signaling pathway—RELA—Barrett's esophagus	0.000192	0.0137	CbGpPWpGaD
Pimecrolimus—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000186	0.0133	CbGpPWpGaD
Pimecrolimus—MTOR—LKB1 signaling events—TP53—Barrett's esophagus	0.000174	0.0124	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000157	0.0112	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—CDKN2A—Barrett's esophagus	0.000153	0.0109	CbGpPWpGaD
Pimecrolimus—MTOR—BDNF signaling pathway—APC—Barrett's esophagus	0.000146	0.0104	CbGpPWpGaD
Pimecrolimus—MTOR—ErbB Signaling Pathway—TP53—Barrett's esophagus	0.000145	0.0103	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—CXCL8—Barrett's esophagus	0.000138	0.00989	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—TP53—Barrett's esophagus	0.000138	0.00983	CbGpPWpGaD
Pimecrolimus—MTOR—Oncostatin M Signaling Pathway—TP53—Barrett's esophagus	0.000125	0.00891	CbGpPWpGaD
Pimecrolimus—MTOR—AMPK Signaling—TP53—Barrett's esophagus	0.000119	0.00849	CbGpPWpGaD
Pimecrolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000119	0.00848	CbGpPWpGaD
Pimecrolimus—MTOR—BDNF signaling pathway—RELA—Barrett's esophagus	0.000114	0.00815	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.000101	0.00724	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	9.86e-05	0.00704	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—SLC9A1—Barrett's esophagus	9.73e-05	0.00695	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	9.72e-05	0.00694	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	9.68e-05	0.00691	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	9.36e-05	0.00669	CbGpPWpGaD
Pimecrolimus—MTOR—B Cell Activation—RELA—Barrett's esophagus	8.95e-05	0.0064	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—GAST—Barrett's esophagus	8.88e-05	0.00635	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—TP53—Barrett's esophagus	8.5e-05	0.00607	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—CDKN2A—Barrett's esophagus	7.3e-05	0.00522	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—RELA—Barrett's esophagus	7.03e-05	0.00502	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—CXCL8—Barrett's esophagus	6.62e-05	0.00473	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—RELA—Barrett's esophagus	6.59e-05	0.00471	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	6.35e-05	0.00454	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—SST—Barrett's esophagus	6.09e-05	0.00435	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—SLC9A1—Barrett's esophagus	5.47e-05	0.00391	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—GAST—Barrett's esophagus	5e-05	0.00357	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—APC—Barrett's esophagus	4.6e-05	0.00329	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—TP53—Barrett's esophagus	4.06e-05	0.0029	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HGF—Barrett's esophagus	3.77e-05	0.0027	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—RELA—Barrett's esophagus	3.76e-05	0.00269	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—RELA—Barrett's esophagus	3.61e-05	0.00258	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—PTGS2—Barrett's esophagus	3.49e-05	0.0025	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—SST—Barrett's esophagus	3.42e-05	0.00245	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—APC—Barrett's esophagus	3.22e-05	0.0023	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—APC—Barrett's esophagus	2.59e-05	0.00185	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—RELA—Barrett's esophagus	2.52e-05	0.0018	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CXCL8—Barrett's esophagus	2.37e-05	0.00169	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PTGES—Barrett's esophagus	2.22e-05	0.00159	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—RELA—Barrett's esophagus	2.19e-05	0.00156	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—PTGS2—Barrett's esophagus	1.96e-05	0.0014	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—APC—Barrett's esophagus	1.81e-05	0.00129	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.69e-05	0.0012	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TP53—Barrett's esophagus	1.46e-05	0.00104	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—RELA—Barrett's esophagus	1.42e-05	0.00101	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CXCL8—Barrett's esophagus	1.33e-05	0.000953	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.22e-05	0.000868	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TP53—Barrett's esophagus	8.19e-06	0.000585	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PPARG—Barrett's esophagus	5.55e-06	0.000396	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	4.36e-06	0.000312	CbGpPWpGaD
